Indeed, the frequent co-occurrence of TP53 and EGFR sequence variants is striking and it might be explained by a p53/miR-193a/EGFR feedback loop mechanism previously reported as a driving force for NSCLC tumorigenesis (Wang et al., 2019). This evidence concerns the gene TP53 and non-small cell lung carcinoma.